Product Description: Finotonlimab (SCT-I10A) is a recombinant humanised IgG PD-1 antibody. Finotonlimab has the potential for solid tumors or lymphomas research[1].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]Hiroshi Yano, et al. Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity. Immunology. 2019 Jul;157(3):232-247.